Physician profile
Edward Green
NPI 1467554220
$4,019.68
in general payments reported to CMS, 2019-2025
13 companies · $23.53 in 2025
The $23.53 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $1,807 · 2021: $1,408 · 2022: $126 · 2023: $293 · 2024: $99.81 · 2025: $23.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $2,776.07 | 2020-2021 | |
| Horizon Therapeutics Plc | $382.30 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $245.60 | 2020-2024 | Quattro, Comprehensive Shoulder System |
| Ortho Development Corporation | $155.40 | 2021 | |
| Medtronic, INC. | $114.45 | 2023 | Intellis Adaptivestim |
| Electronic Waveform Lab, INC. | $107.59 | 2019-2020 | |
| Bioventus LLC | $80.19 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Tersera Therapeutics LLC | $47.34 | 2019 | |
| Depuy Synthes Sales INC. | $35.20 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $26.44 | 2024 | Exparel, Iovera, Zilretta |
| Ermi LLC | $17.15 | 2020 | |
| Smith+Nephew, INC. | $16.34 | 2019 | |
| Ibsa Pharma INC. | $15.61 | 2023 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.